Sort
17,828 grants matching “crispr”
Establishing a Novel Instrumental Model for Elucidating Mitochondrial DNA-Associated Dysfunction and Pathogenicity
$366,102Zengyi Shao · Iowa State University · R35 · FY2025 · GM
Epigenetic mechanisms of therapeutic resistance
$366,098Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Epigenetic mechanisms of therapeutic resistance
$366,097Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma
$366,000Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma
$366,000Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
A novel pathway to overcome resistance to immunotherapy in melanoma
$366,000Diana Nora Vaz Saleiro · Northwestern University At Chicago · R01 · FY2025 · CA
A novel pathway to overcome resistance to immunotherapy in melanoma
$366,000Diana Nora Vaz Saleiro · Northwestern University At Chicago · R01 · FY2024 · CA
A Pathway of Tumor Suppression
$366,000Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
A Pathway of Tumor Suppression
$366,000Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma
$366,000Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
A Pathway of Tumor Suppression
$366,000Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Engineering human-derived programmable RNA effectors to retune gene expression
$365,825Bryan Dickinson · University Of Chicago · R01 · FY2023 · EB
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
$365,811Guang Peng · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
$365,811Guang Peng · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
CRISPR-Cas9 Genome Edited MSCs to Target OA Cartilage Regeneration
$365,803Ming Pei · West Virginia University · R56 · FY2022 · AR
Role of S-nitrosylation in regulating cardiac function and disease
$365,797Elizabeth Murphy · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Understanding the Relationship LNP Structure, Cholesterol Trafficking, and InVivo Delivery
$365,759James Dahlman · Georgia Institute Of Technology · R01 · FY2019 · GM
Second line breast cancer therapy alters aromatase inhibitor resistant metastasis
$365,754Syreeta L Tilghman · Florida Agricultural And Mechanical Univ · SC1 · FY2018 · GM
Development and Validation of a Transgenic Rabbit Model of Dravet Syndrome
$365,703Lori L Isom · University Of Michigan At Ann Arbor · R33 · FY2025 · NS
TET-mediated DNA Demethylation Mechanisms and Epigenome Engineering Applications
$365,625Rahul Manu Kohli · University Of Pennsylvania · R01 · FY2025 · GM
Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia
$365,525Mario Andres Blanco · University Of Pennsylvania · R01 · FY2023 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$365,513Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Project 3 - Modeling Proteasome Inhibitor Response and Resistance in Cell Lines and Patient Samples with Single Cell Analysis of Subpopulations
$365,497Peter Leif Bergsagel · Mayo Clinic Arizona · U54 · FY2019 · CA
CRISPR/Cas9-Based Gene Editing for the Correction of Duchenne Muscular Dystrophy
$365,426Charles A Gersbach · Duke University · R01 · FY2016 · AR
Cell-cell communication mediated by fluid flows
$365,387Daniel T Grimes · University Of Oregon · R35 · FY2023 · GM